| Literature DB >> 32166310 |
Chloe Bryson-Cahn1,2, Jeffrey Duchin1,3, Vanessa A Makarewicz2, Meagan Kay3, Krista Rietberg2, Nathanael Napolitano2, Carole Kamangu2, Timothy H Dellit1, John B Lynch1,2.
Abstract
Thousands of people in the United States have required testing for SARS-CoV-2. Evaluation for a special pathogen is resource intensive. We report an innovative approach to home assessment that, in collaboration with public health, enables safe evaluation and specimen collection outside the healthcare setting, avoiding unnecessary exposures and resource utilization.Entities:
Keywords: COVID-19; SARS-CoV-2; home assessment; novel coronavirus
Mesh:
Year: 2020 PMID: 32166310 PMCID: PMC7108172 DOI: 10.1093/cid/ciaa256
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079